A Multi-center, Single-Arm, Open-Label Phase Ia/Ib Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of GH56 Capsules in Subjects with MTAP-Deleted Advanced Solid Tumors
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs GH 56 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Suzhou Genhouse Bio
- 04 Feb 2025 New trial record